Now that we’ve entered the second half of a challenging and unpredictable year, it’s time to re-look at 2020 goals, and begin the planning and budget cycles for 2021. But how? Maybe it’s the unknowns, maybe it’s concern for the impact goals can have on your team’s morale and motivation—this feels particularly hard this time.
4 min read
3 min read
The CCPA was created with the goal of enhancing the privacy rights of California residents. Going into effect on January 2020, the CCPA requires businesses to take several steps to be compliant. The law is comparable to the EU’s General Data Protection Regulation (GDPR) but takes certain measures even further, like having a broader definition of what constitutes private data.
2 min read
Whether you’re launching your first product or expanding internationally, a strong marketing plan is essential. Ensuring continued growth requires new perspectives and new strategies in many areas of the business. We’ve created a guide with sales and marketing best practices for five different stages of growth. Here are some highlights:
3 min read
Report from XPONENTIAL 2018
With more than 8500 attendees, the AUVSI XPONENTIAL show is the largest event worldwide for drones, robotics, and unmanned systems spanning over 20 different industries. In our second year of attendance at the show, we noticed significant shifts in the market makeup, exhibitor’s strategy, and the unmanned industry as a whole.
3 min read
Whether you’re starting a new company, establishing a spinoff, or considering a total rebrand, your company name is an important decision that will drive a lot of other aspects of your business.
6 min read
Ben Burton, president and CEO of iuvo BioScience, talks with us about his five-year strategic plan, targeting aggressive growth both organically and through mergers and acquisitions. The acquisition of Moog’s laboratory services business and recent divestiture of iuvo’s sterilization facility, LINK, in Erie, PA, will allow the company to focus on investing in expanding testing services.
Ben spent more than eight years at Bausch + Lomb as vice president of quality for its pharmaceutical business. We had the pleasure of tapping into his thought process on acquisition strategy—considering both cultural and branding implications.